Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Blank Check IPOs (SPACS) -- Ignore unavailable to you. Want to Upgrade?

To: Glenn Petersen who wrote (2272)	4/22/2010 7:44:00 AM
From: Glenn Petersen	Respond to of 3862

BBV Vietnam S.E.A Acquisition (stock symbol: [t]BBVVF[t]) has closed on its acquisition of Migami: BBV Vietnam S.E.A. Acquisition Corp. Announces Closing of Business Combination with Migami, Inc. after Stockholders Approve All Proposals Press Release Source: Migami, Inc. On Wednesday April 21, 2010, 5:05 pm EDT HANOI, Vietnam & WOODLAND HILLS, Calif.--(BUSINESS WIRE)--BBV Vietnam S.E.A. Acquisition Corp. (OTCBB: BBVVF - News)(OTCBB:BBVUF - News)(OTCBB:BBVWF - News) (the “Company” or “BBV”) and Migami, Inc. (“Migami”) jointly announced they have completed their previously announced business combination. The Company, which will be known as “Pharmanite Holdings, Inc.,” is the publicly traded holding company of Pharmanite, Inc., its operating subsidiary. Pharmanite, Inc. will continue Migami’s business of developing, commercializing and licensing drug delivery platforms and anti-aging cosmetics worldwide, with a special emphasis on Asia. John Park, the President and Chief Executive Officer of Migami and the new President and Chief Executive Officer of the Company, stated, “This transaction represents an important milestone for Migami and provides us with the platform to execute our growth strategy of developing, commercializing and licensing various drug delivery platforms in Asia. We are excited about Migami’s opportunities for future growth, especially in oncology nano-delivery.” At the Special Meeting of Stockholders held on April 14, 2010, the Company’s stockholders approved the proposed business combination with Migami, Inc. as well as related proposals. Pursuant to the Merger Agreement, the existing officers and directors of BBV resigned at the closing of the transaction, and the senior management and board of directors of Migami remains unchanged and has been appointed to assume the management of the Company. As a result of the transaction, Migami is now the majority stockholder of the Company. The Company intends to promptly file with the Securities and Exchange Commission a Current Report on Form 6-K describing in more detail the transaction discussed in this press release. <snip> finance.yahoo.com